The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Hologic's share price is €65.00.
Hologic's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €15.98. Hence, Hologic's PS Ratio for today is 4.07.
The historical rank and industry rank for Hologic's PS Ratio or its related term are showing as below:
FRA:HO1'
s PS Ratio Range Over the Past 10 Years
Min: 2.47 Med: 3.96 Max: 5.63
Current: 4.16
During the past 13 years, Hologic's highest PS Ratio was 5.63. The lowest was 2.47. And the median was 3.96.
FRA:HO1's PS Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.94
vs FRA:HO1: 4.16
Hologic's Revenue per Sharefor the
three
months ended in Dec. 2025 was €3.96.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €15.98.
Warning Sign:
Hologic Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Hologic was 6.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -2.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 0.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 7.80% per year.
During the past 13 years, Hologic's highest 3-Year average Revenue per Share Growth Rate was 41.90% per year. The lowest was -14.10% per year. And the median was 8.45% per year.
Back to Basics: PS Ratio
Hologic (FRA:HO1) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Hologic PS Ratio Related Terms
Hologic PS Ratio Historical Data
* Premium members only.
The historical data trend for Hologic's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Hologic's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's PS Ratio distribution charts can be found below:
* The bar in red indicates where Hologic's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Hologic's Share Price of today is €65.00. Hologic's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €15.98.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Hologic (FRA:HO1) has a PS Ratio of 4.07 as of Jul. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Hologic and its competitors. This is near median its historical median of 3.96. Over the past decade, Hologic's PS Ratio has ranged from 2.47 to 5.63.
Is Hologic's PS Ratio too high?
Hologic's current PS Ratio of 4.07 is near median its 10-year median of 3.96. Over the past 10 years, this metric has ranged from a low of 2.47 to a high of 5.63. The Medical Devices & Instruments industry median PS Ratio is 2.94. Hologic's value of 4.07 is 38.4% above this industry median. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's PS Ratio compare to WST and COO?
Hologic's PS Ratio of 4.07 can be compared against companies in the Medical Devices & Instruments industry. The industry median PS Ratio is 2.94. Hologic's value of 4.07 is 38.4% above this benchmark. Historically, Hologic's own PS Ratio has ranged from 2.47 to 5.63 over the past decade. While the company's 10-year median is 3.96 vs. the industry median of 2.94, Hologic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hologic's current PS Ratio of 4.07 is 38.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Hologic and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hologic's current PS Ratio is 4.07, which is near median its own 10-year median of 3.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (FRA:HO1) has a current PS Ratio of 4.07. The stock's GF Value™ is €70.17, compared to a current price of €65.00 — trading 7.4% below its estimated fair value. The current PS Ratio is 4.07, which is near median its 10-year median of 3.96 and 38.4% above the Medical Devices & Instruments industry median of 2.94. Hologic's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Hologic (FRA:HO1), the current PS Ratio is 4.07 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hologic (FRA:HO1) Overvalued in 2026?
Based on GuruFocus' analysis, Hologic stock appears to be undervalued.
The current stock price of €65.00 is trading 7.4% below its estimated GF Value™ of €70.17.
Key valuation signals for FRA:HO1:
PS Ratio: 4.07 (near median its 10-year median of 3.96)
GF Value™: €70.17 vs. price of €65.00 (7.4% below fair value)
Industry Position: 38.4% above the Medical Devices & Instruments median
No single metric tells the full story. See the FRA:HO1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score
Get the complete analysis for FRA:HO1
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HO1 has been successfully added to your 
